Home About Us Conditions Erectile Dysfunction Peyronie’s Disease Treatment Premature Ejaculation Treatment Weight Management Treatments Acoustic Shockwave Therapy Hormone Testing Supplements Pharmaceuticals Penis Pump Pelvic Floor Physiotherapy Psychologist FAQ Blog Research Contact Us View Our Locations | Call Us: 905-469-4465 Home About Us Conditions Erectile Dysfunction Peyronie’s Disease Treatment Premature Ejaculation Treatment Weight Management Treatments Acoustic Shockwave Therapy Hormone Testing Supplements Pharmaceuticals Penis Pump Pelvic Floor Physiotherapy Psychologist FAQ Blog Research Contact Us SCHEDULE CONSULTATION Do I Have Erectile Dysfunction? ED Symptoms and Diagnosis
GovernanceAwardsAffiliated SocietiesPast PresidentsHistoryExecutive OfficeContact Differences in Sexual Response for Men During Partnered Sex and Masturbation Is There a Connection Between Erectile Dysfunction and Heart Disease? Treating Erectile Dysfunction With Low-Intensity Shockwave Therapy and Tadalafil: The Results of a New Clinical Trial Erectile Aids: How Helpful Are They for Prostate Cancer Patients? Study Analyzes Diabetes, Mental Health, and Sexual Function During COVID-19 Pandemic In Colombia, Sexual Dysfunction Linked to Higher Rates of LUTS PRP Injections Could be Effective ED Treatment; More Research is Needed Are men with anxiety disorders more likely to develop erectile dysfunction (ED)? Female Sexual Dysfunction Linked to Sexual Problems in Men How can I manage performance anxiety and psychogenic erectile dysfunction (ED)? Men With BPH May Have Better Erectile Function After TUDP Procedures Duplex Doppler Ultrasound in the Evaluation of Patients With Erectile Dysfunction Study Suggests ED Treatment “Disparities” After Radical Prostatectomy Nonorganic ED Might be Managed with Pharmacotherapy Should We Tailor the Clinical Management of Erectile Dysfunction According to Different Ages? Sign up here to receive the ISSM Update (our weekly update) and stay up-to-date on ISSM! HomeFor providersFor PublicSexual Health TopicsQ&AHeadlinesFind a ProviderAboutVision and MissionLeadershipCommitteesBylaws CommitteeCommunication CommitteeConsultation and Guidelines CommitteeDeveloping Countries CommitteeEducation CommitteeEthics CommitteeFinance & Audit CommitteeGrants & Prizes CommitteeHistory CommitteeMembership CommitteeNominating CommitteePublication CommitteeScientific CommitteeYoung Researchers CommitteeYoung Trainees CommitteeGovernanceAwardsAffiliated SocietiesPast PresidentsHistoryExecutive OfficeContact Quick Links What Causes Erectile Dysfunction? Evaluation of a Man Presenting with ED Treatments of Erectile Dysfunction .
Drugs for treating erectile dysfunction can be taken orally, injected directly into the penis, or inserted into the urethra at the tip of the penis. The most commonly used drugs on the market today include:
Lie on the floor and on your side.Place a pillow between your knees. Make sure the pillow is large enough to spread your legs apart.Squeeze your legs together and hold for five seconds, then release.Repeat step three, eight to 10 times, and do three to five sets.
Health care professionals do not routinely obtain imaging tests in the evaluation of erectile dysfunction.
Most men will experience occasional ED. This can be due to triggers such as stress, anxiety or drinking too much alcohol. Frequent erectile dysfunction can be a sign of an underlying health condition or emotional problems. If it happens regularly you should see your GP or visit a sexual health clinic.
All men receiving testosterone replacement need to have periodic measurement of haemoglobin and haematocrit to monitor for erythrocytosis. Feldman HA , Goldstein I , Hatzichristou DG , et al . Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54–61. Araujo AB , Esche GR , Kupelian V , et al . Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 2007;92:4241–7. doi:10.1210/jc.2007-1245 Lindau ST , Schumm LP , Laumann EO , et al . A study of sexuality and health among older adults in the United States. N Engl J Med 2007;357:762–74. doi:10.1056/NEJMoa067423 Shah J . Erectile dysfunction through the ages. BJU Int 2002;90:433–41. doi:10.1046/j.1464-410X.2002.02911.x Mobley D . Early history of inflatable penile prosthesis surgery. Asian J Androl 2015;17:225–9. Roumeguère T , Wespes E , Carpentier Y , et al . Erectile Dysfunction is associated with a high prevalence of hyperlipidemia and coronary Heart Disease Risk European Urology.44:355–9. Klein R , Klein BE , Lee KE , et al . Prevalence of self-reported erectile dysfunction in people with long-term IDDM. Diabetes Care 1996;19:135–41. doi:10.2337/diacare.19.2.135 Larsen SH , Wagner G , Heitmann BL . Sexual function and obesity. Int J Obes 2007;31:1189–98. doi:10.1038/sj.ijo.0803604 McWaine DE , Procci WR . Drug-induced sexual dysfunction. Med Toxicol Adverse Drug Exp 1988;3:289–306. doi:10.1007/BF03259941 Croft H , Settle E , Houser T , et al . A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clin Ther 1999;21(4):643–58. doi:10.1016/S0149-2918(00)88317-4 Janeway M , Baum N . Managing the enlarged prostate gland in elderly men. Clinical Geriatrics http://www.consultant360.com/articles/managing-enlarged-prostate-gland-elderly-men. Kumar RJ , Barqawi A , Crawford ED . Adverse events associated with hormonal therapy for prostate Cancer. Rev Urol 2005;7 Suppl 5:S37–S43. Aksam A , Yassin A , Saad F . Testosterone and erectile dysfunction. J Andrology 2008;29. Gades NM , Nehra A , Jacobson DJ , et al . Association between smoking and erectile dysfunction: a population-based study. Am J Epidemiol 2005;161:346–51. doi:10.1093/aje/kwi052 Mobley D , Baum N . Smoking: it’s impact on urologic conditions. Rev Urology 17 2015. Stein RA . Endothelial dysfunction, erectile dysfunction, and coronary heart disease: the pathophysiologic and clinical linkage. Rev Urol 2003;5(Suppl 7):S21–S27. Andersson K , Stief C . Penile erection and cardiac risk: pathophysiologic and pharmacologic mechanisms. Am J Cardiol 2000;86:23–6. doi:10.1016/S0002-9149(00)00887-0 Feldman HA , Johannes CB , Derby CA , et al . Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 2000;30:328–38. doi:10.1006/pmed.2000.0643 Vlachopoulos C , Ioakeimidis N , Terentes-Printzios D , et al . The triad: erectile dysfunction-endothelial dysfunction-cardiovascular disease Curr Pharm Des. 2008;14:3700–14. Watts GF , Chew KK , Stuckey BG et al . The erectile-endothelial dysfunction nexus: new opportunities for cardiovascular risk prevention. Nat Clin Pract Cardiovasc Med 2007;4:263–73. doi:10.1038/ncpcardio0861 Montorsi F , Briganti A , Salonia A , et al . Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 2003;44:360–5. doi:10.1016/S0302-2838(03)00305-1 Vlachopoulos C , Rokkas K , Ioakeimidis N , et al . Prevalence of asymptomatic coronary artery disease in men with vasculogenic erectile dysfunction: a prospective angiographic study. Eur Urol 2005;48:996–1003. doi:10.1016/j.eururo.2005.08.002 Mulhall J , Teloken P , Barnas J et al . Vasculogenic erectile dysfunction is a predictor of abnormal stress echocardiography. J Sex Med 2009;6:820–5. doi:10.1111/j.1743-6109.2008.01087.x Hodges LD , Kirby M , Solanki J , et al . The temporal relationship between erectile dysfunction and cardiovascular disease. Int J Clin Pract 2007;61:2019–25. doi:10.1111/j.1742-1241.2007.01629.x Inman BA , Sauver JL , Jacobson DJ , et al . A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 2009;84:108–13. doi:10.4065/84.2.108 Ponholzer A , Temml C , Obermayr R , et al . Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke? Eur Urol 2005;48:512–8. doi:10.1016/j.eururo.2005.05.014 Thompson IM , Tangen CM , Goodman PJ , et al . Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005;294:2996–3002. doi:10.1001/jama.294.23.2996 Banks E , Joshy G , Abhayaratna WP , et al . Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort study. PLoS Med 2013;10:e1001372. doi:10.1371/journal.pmed.1001372 Lewis RW , Fugl-Meyer KS , Corona G , et al . Definitions/epidemiology/risk factors for sexual dysfunction. J Sex Med 2010;7:1598–607. doi:10.1111/j.1743-6109.2010.01778.x Yaman O , Gulpinar O , Hasan T , et al . Erectile dysfunction may predict coronary artery disease: relationship between coronary artery calcium scoring and erectile dysfunction severity. Int Urol Nephrol 2008;40:117–23. doi:10.1007/s11255-007-9293-8 Montorsi P , Ravagnani PM , Galli S , et al . Association between erectile dysfunction and coronary artery disease. role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J 2006;27:2632–9. doi:10.1093/eurheartj/ehl142 Montorsi P , Ravagnani PM , Galli S , et al . Association between erectile dysfunction and coronary artery disease:matching the right target with the right test in the right patient. Eur Urol 2006;50:721–31. doi:10.1016/j.eururo.2006.07.015 Yassin AA , Saad F . Testosterone and erectile dysfunction. J Androl 2008;29:593–604. doi:10.2164/jandrol.107.004630 Khera M . Androgens and erectile function: a case for early androgen use in postprostatectomy hypogonadal men. J Sex Med 2009;6:234–8. doi:10.1111/j.1743-6109.2008.01159.x Aversa A , Isidori AM , De Martino MU , et al . Androgens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction. Clin Endocrinol 2000;53:517–22. doi:10.1046/j.1365-2265.2000.01118.x Wespes E , Amar E , Hatzichristou D , et al . EAU guidelines on erectile dysfunction: an update. Eur Urol 2006;49:806–15. doi:10.1016/j.eururo.2006.01.028
If you have a sexual partner, it may be useful to attend this consultation together.
As sexual activity often involves a partner, it is important to try to involve the partner in the evaluation and management of erectile dysfunction and determine if assistance with relationship problems will be needed. Sex therapists are helpful in assisting couples deal with sexual relationship difficulties.
Atherosclerosis (narrowing of the arteries)DiabetesHigh blood pressureSmokingUrological problemsPeyronie’s diseasePelvic traumaPelvic floor dysfunctionIncontinence
Other medical therapies under evaluation include ROCK inhibitors and soluble guanyl cyclase activators. Melanocortin receptor agonists are a new set of medications being developed in the field of erectile dysfunction. Their action is on the nervous system rather than the vascular system. PT-141 is a nasal preparation that appears to be effective alone or in combination with PDE5 inhibitors. The main side effects include flushing and nausea. These drugs are currently not approved for commercial use.
Titrating doses of injectable impotence medications that are administered in a physician's office and the accompanying office visits are considered medically necessary. This includes in office titrating doses of papaverine, alprostadil (prostaglandin E1 or Caverject) and phentolamine. Except for phentolamine, which is not generally used alone, these drugs can be used alone or in combination. The drug MUSE, a pellet from of alprostadil, is also used as an alternative to alprostadil injections.
Research suggests that avid bikers are more likely to get ED than other athletes. Some bicycle seats put pressure on the perineum, an area between the anus and scrotum full of arteries and nerves vital to sexual arousal. If you bike for many hours each week, get a seat designed to protect this area.
“We knew that physical activity reduces the risk of erectile dysfunction, but here we see clearly that it could also be a form of treatment. This makes sense because when you create better flow through the blood vessels, you are actually treating the very cause of erectile dysfunction. So I think that this study could very well lead to a treatment,” she says.
What we treatErectile DysfunctionHair LossPremature EjaculationSleepAcneDaily Skin RoutineGenital HerpesCold Sores
Another relatively simple, non-invasive treatment for ED includes use of a vacuum erection device (‘penile pump’), to assist with achieving erection for intercourse. These devices work by pulling blood into the penis; a tight constrictive ring is then placed at the base of the penis. While generally safe, care should be taken not to overinflate the device nor to leave the constrictive ring on for prolonged periods as either of these may lead to penile damage.
If you have a problem getting or keeping an erection hard enough for you to have sex with your partner, you may have erectile dysfunction. The condition is common in men over 40 years of age, although it can affect men of all ages. Symptoms may differ from person to person. Some men do not get an erection at all, others may be able to get an erection but can’t maintain it long enough for sex and some men get an erection, but it is not hard enough for sex. Lose weight if you are overweight Stop smoking, as it damages blood vessels Don’t drink more than 14 units of alcohol per week Eat a healthy, balanced diet Exercise regularly Try to reduce your stress levels